Skip to content
Sign in

LFVN · NASDAQ

Lifevantage (LFVN) Stock Price & Fundamentals

$1,028.78+0.23%+$2.41End-of-day price as of Oct 9, 2026

Lifevantage (LFVN) closed at $1,028.78 on Oct 9, 2026, up 0.23% from the previous close of $1,026.37.

Share price, past year

1Y +32.43%

52-week range $768.05 – $1,028.78. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,028.78
Sep 30, 2026$986.70
Aug 31, 2026$957.76
Jul 31, 2026$897.30
Jun 30, 2026$905.43
May 29, 2026$895.32
Apr 30, 2026$931.83
Mar 31, 2026$959.94
Feb 27, 2026$924.75
Jan 30, 2026$916.31
Dec 31, 2025$837.20
Nov 28, 2025$786.60
Oct 31, 2025$797.29

Key statistics

Market cap
$12.88B
P/E (TTM)
2,572.0
EPS (TTM)
$0.40
Revenue (TTM)
$182.59M
Net income (TTM)
$5.07M
Shares outstanding
12.5M
Dividend yield
—
52-week range
$768.05 – $1,028.78

Lifevantage's market cap is $12.88B, based on a share price of $1,028.78 and 12.5M shares outstanding as of Jun 30, 2026.

Financials

Lifevantage reported revenue of $182.59M for fiscal 2026, down 20.10% from fiscal 2025.

Lifevantage earned net income of $5.07M in fiscal 2026, a net margin of 2.8%.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Annual revenue by fiscal year; the table below lists the values.
Lifevantage annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2026ended Jun 30, 2026$182.59M−20.1%$5.07M2.8%$0.40$6.67M
FY2025ended Jun 30, 2025$228.53M+14.2%$9.81M4.3%$0.75$10.51M
FY2024ended Jun 30, 2024$200.16M−6.2%$2.94M1.5%$0.23$9.95M
FY2023ended Jun 30, 2023$213.40M+3.4%$2.54M1.2%$0.20$3.76M
FY2022ended Jun 30, 2022$206.36M−6.3%$3.12M1.5%$0.24$6.43M
FY2021ended Jun 30, 2021$220.18M−5.5%$12.89M5.9%$0.90$12.53M
FY2020ended Jun 30, 2020$232.92M+3.1%$11.55M5.0%$0.79$15.65M
FY2019ended Jun 30, 2019$225.96M+11.2%$7.43M3.3%$0.50$15.28M
FY2018ended Jun 30, 2018$203.20M+1.9%$5.76M2.8%$0.41$8.61M
FY2017ended Jun 30, 2017$199.49M—$1.61M0.8%$0.11$5.54M
Lifevantage quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q4 FY2026ended Jun 30, 2026$42.38M$1.28M$0.10
Q3 FY2026ended Mar 31, 2026$43.72M$1.36M$0.11
Q2 FY2026ended Dec 31, 2025$48.93M$276.00K$0.02
Q1 FY2026ended Sep 30, 2025$47.56M$2.16M$0.17
Q4 FY2025ended Jun 30, 2025$55.11M$1.96M$0.16
Q3 FY2025ended Mar 31, 2025$58.44M$3.47M$0.26
Q2 FY2025ended Dec 31, 2024$67.76M$2.55M$0.19
Q1 FY2025ended Sep 30, 2024$47.21M$1.83M$0.14

Company profile

Name
Lifevantage Corp
Ticker
LFVN
Exchange
NASDAQ
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
3300 Triumph Blvd, Suite 700, Lehi, UT 84043
Fiscal year ends
December
SEC CIK
0000849146

Recent SEC filings

Frequently asked questions

What is Lifevantage's stock price?

Lifevantage (LFVN) closed at $1,028.78 on Oct 9, 2026, up 0.23% from the previous close of $1,026.37.

What is Lifevantage's market cap?

Lifevantage's market cap is $12.88B, based on a share price of $1,028.78 and 12.5M shares outstanding as of Jun 30, 2026.

How much revenue does Lifevantage make?

Lifevantage reported revenue of $182.59M for fiscal 2026, down 20.10% from fiscal 2025.

What is LFVN's P/E ratio?

Lifevantage's price-to-earnings ratio is 2,572.0, based on trailing twelve-month diluted EPS of $0.40.

Does Lifevantage pay a dividend?

Lifevantage's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Lifevantage Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures